HighTower Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16M Buy
28,526
+1,026
+4% +$658K 0.02% 693
2025
Q4
$18.6M Sell
27,500
-219
-0.8% -$149K 0.02% 633
2025
Q3
$17.7M Sell
27,719
-4,259
-13% -$2.59M 0.02% 636
2025
Q2
$17.2M Buy
31,978
+2,349
+8% +$1.12M 0.02% 601
2025
Q1
$12.4M Sell
29,629
-203
-0.7% -$88.1K 0.02% 685
2024
Q4
$12.3M Sell
29,832
-640
-2% -$281K 0.02% 670
2024
Q3
$15.5M Buy
30,472
+9
+0% +$4.37K 0.02% 589
2024
Q2
$14.8M Sell
30,463
-720
-2% -$361K 0.02% 574
2024
Q1
$16.9M Sell
31,183
-4,855
-13% -$2.65M 0.03% 528
2023
Q4
$20M Buy
36,038
+1,821
+5% +$855K 0.03% 473
2023
Q3
$14.9M Buy
34,217
+1,468
+4% +$732K 0.03% 541
2023
Q2
$16.5M Buy
32,749
+816
+3% +$391K 0.03% 486
2023
Q1
$16.1M Sell
31,933
-2,122
-6% -$1.02M 0.04% 470
2022
Q4
$13.9M Sell
34,055
-1,211
-3% -$470K 0.03% 507
2022
Q3
$11.5M Buy
35,266
+2,503
+8% +$919K 0.03% 514
2022
Q2
$11.5M Sell
32,763
-1,011
-3% -$412K 0.03% 525
2022
Q1
$18.5M Sell
33,774
-3,449
-9% -$1.81M 0.04% 406
2021
Q4
$24.5M Buy
37,223
+1,061
+3% +$666K 0.05% 334
2021
Q3
$22.5M Buy
36,162
+1,930
+6% +$1.3M 0.06% 314
2021
Q2
$21.6M Buy
34,232
+466
+1% +$257K 0.06% 296
2021
Q1
$16.5M Buy
33,766
+126
+0.4% +$63.1K 0.05% 337
2020
Q4
$16.8M Buy
33,640
+1,055
+3% +$472K 0.07% 266
2020
Q3
$12.8M Buy
32,585
+85
+0.3% +$31.4K 0.06% 284
2020
Q2
$10.7M Buy
32,500
+77
+0.2% +$22.3K 0.06% 300
2020
Q1
$7.85M Sell
32,423
-173
-0.5% -$45.1K 0.05% 332
2019
Q4
$8.51M Sell
32,596
-2,195
-6% -$578K 0.05% 377
2019
Q3
$9.45M Buy
34,791
+2,339
+7% +$651K 0.05% 351
2019
Q2
$8.94M Sell
32,452
-749
-2% -$185K 0.05% 354
2019
Q1
$7.42M Sell
33,201
-226
-0.7% -$46.7K 0.05% 375
2018
Q4
$6.21M Sell
33,427
-61,140
-65% -$12.5M 0.05% 395
2018
Q3
$23.6M Buy
94,567
+59,130
+167% +$14.4M 0.17% 122
2018
Q2
$7.72M Buy
35,437
+2,514
+8% +$518K 0.06% 351
2018
Q1
$6.3M Buy
32,923
+2,558
+8% +$472K 0.05% 397
2017
Q4
$4.75M Sell
30,365
-830
-3% -$131K 0.04% 490
2017
Q3
$4.85M Buy
31,195
+120
+0.4% +$19K 0.04% 473
2017
Q2
$5.02M Sell
31,075
-903
-3% -$147K 0.04% 459
2017
Q1
$4.94M Buy
31,978
+2,479
+8% +$342K 0.05% 438
2016
Q4
$3.46M Sell
29,499
-761
-3% -$86.8K 0.04% 519
2016
Q3
$3.41M Buy
30,260
+1,492
+5% +$157K 0.04% 490
2016
Q2
$2.67M Sell
28,768
-8,559
-23% -$735K 0.03% 527
2016
Q1
$2.92M Sell
37,327
-958
-3% -$69K 0.01% 576
2015
Q4
$2.8M Buy
38,285
+12,481
+48% +$890K 0.03% 507
2015
Q3
$1.92M Buy
25,804
+4,687
+22% +$336K 0.03% 634
2015
Q2
$1.35M Sell
21,117
-159
-0.7% -$11K 0.02% 647
2015
Q1
$1.64M Buy
21,276
+88
+0.4% +$6.85K 0.02% 651
2014
Q4
$1.57M Buy
21,188
+764
+4% +$53.6K 0.02% 660
2014
Q3
$1.2M Sell
20,424
-1,102
-5% -$69.7K 0.02% 714
2014
Q2
$1.44M Buy
21,526
+1,704
+9% +$108K 0.02% 673
2014
Q1
$1.2M Buy
19,822
+1,322
+7% +$78.8K 0.02% 678
2013
Q4
$984K Sell
18,500
-25,658
-58% -$1.35M 0.02% 700
2013
Q3
$2.2M Buy
44,158
+11,158
+34% +$536K 0.06% 393
2013
Q2
$1.48M Buy
+33,000
New +$1.44M 0.04% 473

Other funds holding IDXX

HighTower Advisors's IDXX Position: Q1 2026 in Review

HighTower Advisors increased its Idexx Laboratories (IDXX) stake by 3.7% in Q1 2026, buying an estimated $658K and bringing the position to 28,526 shares worth $16M. The position accounts for 0.02% of the portfolio, ranked #693.

HighTower Advisors first reported a position in IDXX in Q2 2013 and has held it in 52 quarters since. The position peaked at $24.5M in Q4 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • HighTower Advisors held 28,526 shares of Idexx Laboratories worth $16M as of Q1 2026.
  • HighTower Advisors bought 1,026 Idexx Laboratories shares in Q1 2026, an estimated $658K.
  • Idexx Laboratories made up 0.02% of HighTower Advisors's portfolio in Q1 2026, its #693 holding.
  • HighTower Advisors first reported a position in Idexx Laboratories in Q2 2013 and has held it in 52 quarters since.
  • HighTower Advisors's Idexx Laboratories position peaked at $24.5M in Q4 2021.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.